Innate Pharma SA (NASDAQ:IPHA)
| 6.45 Delayed Data As of Jul 07 |  0.00 / 0.00%Today’s Change | 3.30 Today|||52-Week Range 8.24 | +0.16% Year-to-Date |
Latest IPHA News | Press Releases
No recent news for Innate Pharma SA.
Today’s Trading
| Previous close | 6.45 |
| Today’s open | 6.47 |
| Day’s range | 6.45 - 6.47 |
| Volume | 600 |
| Average volume (3 months) | 12,239 |
| Market cap | $506.8M |
Data as of 3:47pm ET, 07/07/2020
Growth & Valuation
| Earnings growth (last year) | -667.48% |
| Earnings growth (this year) | -2.70% |
| Earnings growth (next 5 years) | -22.50% |
| Revenue growth (last year) | -18.09% |
| P/E ratio | NM |
| Price/Sales | 5.58 |
| Price/Book | 2.08 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| VKTXViking Therapeutics ... | -0.07 | -1.02% |
| MIRMMirum Pharmaceutical... | -0.56 | -2.85% |
| BYSIBeyondspring Inc | -0.59 | -3.73% |
| CRNXCrinetics Pharmaceut... | -0.23 | -1.48% |
Data as of 3:59pm ET, 07/10/2020
Financials
| Next reporting date | -- |
| EPS forecast (this quarter) | -- |
| Annual revenue (last year) | $77.2M |
| Annual profit (last year) | -$23.2M |
| Net profit margin | -30.10% |
Profile
Sector Health Technology |
Industry Biotechnology |
No executives to display |
Corporate headquarters --, -- |
Forecasts
Chart unavailable
